Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sanofi’s Kadmon Bolt-On Bolsters Its General Medicine Division
Deal Adds Transplant Pill Rezurock For Chronic Graft-Versus-Host Disease
Sep 08 2021
•
By
Sten Stovall
Sanofi Is Paying $1.9bn cash for US Biotech • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business